Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 5Mesothelioma, Malignant 4Lung Neoplasms 4Laryngeal Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Mouth Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Medulloblastoma 2Lymphoid Interstitial Pneumonia 2Gallbladder Neoplasms 2Carcinoma 2Vaginal Neoplasms 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sinonasal undifferentiated carcinoma 1Prostatic Neoplasms 1Penile Neoplasms 1PRETEXT I Hepatoblastoma 1Lymphatic Metastasis 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1

Interventions

Paclitaxel 17Carboplatin 16Magnetic Resonance Spectroscopy 11Taxes 10Specimen Handling 10Bevacizumab 10olaparib 9Gemcitabine 9pembrolizumab 8Immunoglobulin G 7Disulfides 7Biopsy 7liposomal doxorubicin 6Doxorubicin 5cediranib 4Nivolumab 4Cyclophosphamide 4Cisplatin 4oregovomab 3niraparib 3adavosertib 3X-Rays 3Topotecan 3tremelimumab 2rucaparib 2mirvetuximab soravtansine 2berzosertib 2aldesleukin 2Surveys and Questionnaires 2Platinum 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Fallopian Tube Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT01970722 2026-03-05

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

City of Hope Medical Center

Phase 1 Active not recruiting
40 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡